You are here

Research

Difficulties with clinical trials.

Eight months into the COVID-19 pandemic in the U.S., it remains unclear whether two of the most promising treatments actually work.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

For Quick Coronavirus Testing, Israel Turns to a Clever Algorithm

BEERSHEBA, Israel — A team of three Israeli scientists has pioneered a coronavirus testing procedure that they say is faster and more efficient than any now in use, testing samples in pools of as many as 48 people at once.

The Israeli government plans to roll out the new method in 12 labs across the country by October, anticipating that another wave of coronavirus infections could coincide with influenza season with potentially calamitous results. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

This Trawler’s Haul: Evidence That Antibodies Block the Coronavirus

 

A fishing vessel that left Seattle in May returned with an unexpected catch: the first direct evidence in humans that antibodies to the coronavirus can thwart infection.

More than a hundred crew members aboard the American Dynasty were stricken by the infection over 18 days at sea. But three sailors who initially carried antibodies remained virus-free, according to a new report.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Trail of bubbles leads scientists to new coronavirus clue

doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Covid-19: Blood Plasma Authorization Is Put on Hold

Last week, just as the Food and Drug Administration was preparing to issue an emergency authorization for blood plasma as a Covid-19 treatment, a group of top federal health officials including Dr. Anthony S. Fauci intervened, arguing that emerging data on the treatment was too weak, according to two senior administration officials.

The authorization is on hold for now as more data is reviewed, according to H. Clifford Lane, the clinical director at the National Institute of Allergy and Infectious Diseases. An emergency approval could still be issued in the near future, he said.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks